View highlights and coverage from leading international Neurology congresses
Valued editorial board member Jeffrey Cummings (University of Nevada, Las Vegas [UNLV], and Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA) shares exciting insights from the session he co-chaired at AAIC20 entitled ‘Microbiome in Alzheimer’s Disease: Pathogenesis and Treatment Implications’. Questions 1. Could you give us a brief overview of the role of […]
Professor Emeritus of Addiction Medicine, Hannu Alho (University of Helsinki, Finland) discusses the need for effective treatment options to manage alcohol use disorder, focusing on odansetron as a newly emerging possibility. Ondansetron is a specific 5HT3-receptor antagonist, which blocks 5HT3 receptors in the gastrointestinal tract and central nervous system, and has been used since the […]
Hans-Christoph Diener (Medical Faculty of the University of Duisburg-Essen, Institute for Medical Informatics, Biometry and Epidemiology, Essen, Germany), talks to us around the highlights of his recently published co-authored review article entitled: Patent Foramen Ovale Closure—Addressing the Unmet Need for Reducing the Risk of Ischemic Stroke, freely available to access here. Questions 1. What is […]
Christoph U Correll (Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA) shares his expert insights on the rationale for combined therapy with olanzapine and samidorphan for the management of patients with schizophrenia. He also provides an overview of the key efficacy and safety findings of the recent phase III ENLIGHTEN-2 study, which evaluated weight […]
Christoph U Correll (Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA) shares his expert insights on the rationale for combined therapy with olanzapine and samidorphan for the management of patients with schizophrenia. He also provides an overview of the key efficacy and safety findings of the recent phase III ENLIGHTEN-2 study, which evaluated weight gain […]
“It is difficult to evaluate what did not happen.” – Academician, LV Gromashevsky The COVID-19 pandemic may be considered the first global health catastrophe in the past 100 years, since it has affected not only economic, political and medical paradigms, but also our way of life. The rate and distribution of the SARS-CoV-2 virus, despite […]
Video produced by and shared with kind authorisation of the European Academy of Neurology (EAN). On World Brain Day 2020, Professor Günther Deuschl, EAN Past President, gets interviewed by Professor Elena Moro, EAN Secretary General, about research and treatment on Parkinson’s disease.
Video produced by and shared with kind authorisation of the European Academy of Neurology (EAN). On this World Brain Day, the European Federation of Neurological Associations (EFNA) president Joke Jaarsma is interviewing two patients with Parkinson’s disease (PD) on their views to improve clinical care in PD. Veerle Aertsen, vice-president of RaDiOrg, the Belgian Rare Diseases Organisation, […]
Get the latest clinical insights from touchNEUROLOGY
